Why Shares of AST SpaceMobile Slipped 27% Last Month

AST SpaceMobile shares fell 27% in October and are down 71% from their highs, as satellite deployment delays and potential competition from SpaceX's Starlink weigh on the outlook. Management says the company needs at least 45 satellites in orbit to begin service in the U.S. and select markets, versus 13 today; last quarter's free cash flow was negative $719 million. At a $15 billion market capitalization, the article argues the stock remains overvalued, noting that even $1 billion in revenue would imply a 15x price-to-sales ratio, and recommends avoiding the shares.

Analysis

The key risk is not simply delayed revenue: ASTS is dependent on a launch provider that also has an incentive to prioritize its own competing direct-to-device service. That creates potential schedule and strategic-control risk even if ASTS’s technology performs as claimed. The implication is a wider range of outcomes for ASTS than a standard deployment delay: each slip can extend the period before commercial validation while increasing the importance of liquidity, financing terms, and dilution. The reported quarterly cash-flow figure should not be annualized without checking cash balances, capex timing, and committed launch costs.

For SpaceX (SPCX), ASTS demand may support launch activity at the margin, but the more consequential potential benefit is control over a scarce deployment channel while building a competing service. Whether that translates into material economics depends on launch prioritization and the economics of its own direct-to-device offering; neither is established here. Telco partners could gain bargaining leverage if multiple satellite providers compete, while ASTS’s prospective wholesale economics remain unproven.

Contrarian view: the 71% drawdown is not itself evidence of value. Investors may still be capitalizing technical validation as though it guarantees timely coverage and attractive unit economics. Conversely, a confirmed acceleration in launches or a credible financing/partnering update could produce a sharp squeeze in a high-volatility name. Immediate price action may be sentiment-driven; the 1–3 month test is launch cadence and liquidity disclosure, while the 6–18 month question is whether coverage converts into paid usage at viable economics.

Key Decisions for Investors

• Do not buy ASTS solely on the drawdown. Keep it on a milestone watchlist pending verified launch dates, deployment cadence, cash runway, and evidence of commercial terms with telecom partners.
• For existing ASTS exposure, consider reducing position risk or using a defined-risk hedge rather than an unhedged short: launch delays or financing dilution could hurt, but a schedule/partnering surprise could trigger a sharp rebound. Reassess if management misses its next disclosed deployment milestones or reports materially weaker liquidity.
• A relative-value ASTS-underweight versus SPCX-overweight is a conditional candidate, not a clean hedge: it expresses launch-priority and competitive-positioning risk, but depends on SPCX investability, valuation, and the degree to which its own service competes. Confirm those details before sizing.
• Falsifiers: sustained acceleration toward the stated coverage threshold, funded deployment plans without materially dilutive terms, or disclosed telco commitments that demonstrate paid demand would weaken the bearish thesis. Continued schedule slippage, deteriorating cash runway, or evidence of Starlink service readiness ahead of ASTS would strengthen it.